With PDUFA Date Coming Up, HGSI Optimistically Outlines Launch Plans For Benlysta
Assuming the lupus drug gets FDA approval, HGSI and its 50-50 partner GlaxoSmithKline are ready to launch Benlysta by the end of the first quarter.
Assuming the lupus drug gets FDA approval, HGSI and its 50-50 partner GlaxoSmithKline are ready to launch Benlysta by the end of the first quarter.